Lucid Diagnostics Inc.(NasdaqGM:LUCD) dropped from Russell Microcap Value Index
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.04 USD | +11.86% | +38.54% | -26.24% |
03-27 | Cantor Fitzgerald Trims Price Target on Lucid Diagnostics to $3 From $3.80, Maintains Overweight Rating | MT |
03-26 | Transcript : Lucid Diagnostics Inc., Q4 2023 Earnings Call, Mar 26, 2024 |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-26.24% | 51.78M | |
+73.17% | 12.38B | |
-15.87% | 8.2B | |
+17.74% | 7.3B | |
+10.58% | 5.32B | |
+33.33% | 4.78B | |
-18.88% | 4.16B | |
-35.55% | 2.43B | |
+1.24% | 2.05B | |
+9.66% | 1.98B |
- Stock Market
- Equities
- LUCD Stock
- News Lucid Diagnostics Inc.
- Lucid Diagnostics Inc.(NasdaqGM: LUCD) dropped from Russell Microcap Value Index